Key Takeaways
- • Anchor PE accelerating Korea M&A deployment: Anchor Equity Partners is executing an aggressive deal pipeline with a target to deploy 900 billion won (approximately $690 million USD) by year-end 2026, signaling confidence in the Korean market despite recent portfolio challenges.
- • Dermafirm repositioning underway: Anchor PE has reorganized Dermafirm's equity structure and appointed Lee Han-gu, former L'Oréal CFO, as finance chief to improve operational performance and resume the sale process for the high-functionality derma cosmetics brand.
- • Growing PE activity in South Korea: Financial sponsors are driving increased M&A activity in Korea, with sponsor-led exits totaling $4.2 billion across 13 deals in H1 2023, reflecting a 46% year-on-year increase in deal count and 75% growth in deal value.
- • Anchor PE's Korea footprint expanding: The firm has grown its portfolio significantly since closing its debut Korea fund at $500 million, with current positions including Dermafirm (68.7%+ equity stake) and previous investments like E-Land and Etus, demonstrating sustained commitment to the Korean alternative investment market.
Summary
Anchor Equity Partners is accelerating its mergers and acquisitions activity in South Korea with an explicit deployment target of 900 billion won by year-end 2026. This expansion reflects the Seoul-based private equity manager's conviction in Korean market opportunities and its ability to source and execute transactions in the region, even as broader macroeconomic conditions remain uncertain.
The most visible near-term initiative involves the repositioning of Dermafirm, Anchor PE's high-functionality derma cosmetics portfolio company. The firm has recently appointed Lee Han-gu, a finance executive with extensive experience at global consumer goods leaders L'Oréal and Procter & Gamble as well as at precision optics manufacturer ZEISS, as the company's chief financial officer. Lee's appointment—reportedly achieved after sustained recruitment efforts—signals Anchor PE's commitment to elevating operational and financial management at the business ahead of a planned exit. Lee brings relevant precedent, having overseen the acquisition of Style Nanda while at L'Oréal. Anchor PE acquired its initial 15% stake in Dermafirm in 2019 and has since increased its ownership to approximately 68.7% through a 2020 capital increase, with total invested capital reaching around 100 billion won.
Anchor PE's deployment acceleration reflects a broader wave of private equity activity reshaping South Korea's M&A landscape. Financial sponsors executed exits totaling $4.2 billion across 13 transactions in the first half of 2023 alone, representing a 46% year-on-year increase in deal count and a 75% increase in aggregate exit value. The firm's debut Korea fund closed on its $500 million target, underpinning the capital base now being deployed across multiple sectors and portfolio stages.
The 900 billion won deployment target by year-end 2026 represents a material acceleration from Anchor PE's historical transaction pace, suggesting the firm is either executing multiple mid-market deals simultaneously or pursuing a larger platform acquisition. This activity occurs against a backdrop of mixed performance in some portfolio companies—Etus, for example, has faced operational headwinds, with operating profit declining from 21.4 billion won in 2023 to near-zero levels in 2024 and turning negative in 2025—underscoring the importance of active portfolio management and timely exits for PE returns in the Korean market.
The most visible near-term initiative involves the repositioning of Dermafirm, Anchor PE's high-functionality derma cosmetics portfolio company. The firm has recently appointed Lee Han-gu, a finance executive with extensive experience at global consumer goods leaders L'Oréal and Procter & Gamble as well as at precision optics manufacturer ZEISS, as the company's chief financial officer. Lee's appointment—reportedly achieved after sustained recruitment efforts—signals Anchor PE's commitment to elevating operational and financial management at the business ahead of a planned exit. Lee brings relevant precedent, having overseen the acquisition of Style Nanda while at L'Oréal. Anchor PE acquired its initial 15% stake in Dermafirm in 2019 and has since increased its ownership to approximately 68.7% through a 2020 capital increase, with total invested capital reaching around 100 billion won.
Anchor PE's deployment acceleration reflects a broader wave of private equity activity reshaping South Korea's M&A landscape. Financial sponsors executed exits totaling $4.2 billion across 13 transactions in the first half of 2023 alone, representing a 46% year-on-year increase in deal count and a 75% increase in aggregate exit value. The firm's debut Korea fund closed on its $500 million target, underpinning the capital base now being deployed across multiple sectors and portfolio stages.
The 900 billion won deployment target by year-end 2026 represents a material acceleration from Anchor PE's historical transaction pace, suggesting the firm is either executing multiple mid-market deals simultaneously or pursuing a larger platform acquisition. This activity occurs against a backdrop of mixed performance in some portfolio companies—Etus, for example, has faced operational headwinds, with operating profit declining from 21.4 billion won in 2023 to near-zero levels in 2024 and turning negative in 2025—underscoring the importance of active portfolio management and timely exits for PE returns in the Korean market.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.